Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal hemochromatosis.

A S Knisely1, Giorgina Mieli-Vergani, Peter F Whitington

  • 1Institute of Liver Studies, King's College Hospital, London, UK.

Gastroenterology Clinics of North America
|October 18, 2003
PubMed
Summary

Neonatal hemochromatosis causes iron overload in fetuses, leading to severe liver damage and often death. Maternal factors may influence recurrence, and immunomodulation might reduce disease severity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

How Real Is Seronegative Autoimmune Hepatitis?

Liver international : official journal of the International Association for the Study of the Liver·2026
Same author

Regulatory T-cells in autoimmune hepatitis: An historical perspective with hints to the future.

JHEP reports : innovation in hepatology·2026
Same author

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.

European journal of gastroenterology & hepatology·2026
Same author

Can we cure autoimmune hepatitis?

Current opinion in immunology·2025
Same author

HLA alleles predisposing to autoimmunity are linked to impaired immunoregulation in patients with juvenile autoimmune liver disease and in their first-degree relatives.

Journal of autoimmunity·2025
Same author

Correction: Exome sequencing reveals IFT172 variants in patients with non-syndromic cholestatic liver disease.

PloS one·2025

Area of Science:

  • Reproductive biology
  • Pediatric pathology
  • Genetics

Background:

  • Neonatal hemochromatosis (NH) is a rare gestational disorder characterized by excessive fetal iron accumulation.
  • The iron distribution mimics hereditary hemochromatosis, primarily causing extensive liver damage.
  • Clinical outcomes include significant fetal loss or early neonatal death.

Purpose of the Study:

  • To investigate the underlying mechanisms of neonatal hemochromatosis.
  • To explore potential maternal factors contributing to NH recurrence.
  • To evaluate the efficacy of immunomodulation in managing at-risk pregnancies.

Main Methods:

  • Review of clinical cases and genetic analyses.
  • Epidemiological study of recurrence rates within families.
  • Analysis of treatment outcomes with immunomodulatory therapies.

Main Results:

  • NH presents with severe hepatic iron deposition and associated mortality.
  • Recurrence rates suggest a genetic component beyond simple autosomal-recessive inheritance, possibly involving maternal factors.
  • Immunomodulatory interventions showed a potential to mitigate disease severity.

Conclusions:

  • Neonatal hemochromatosis is a severe condition with complex inheritance patterns.
  • Maternal influence is a key area for further research in NH.
  • Immunomodulation offers a promising therapeutic strategy for affected pregnancies.

Related Experiment Videos